ArticleThe American journal of emergency medicine2026
Automatic phenotyping of emergency department patients with incidental hepatic steatosis: A machine learning clustering analysis.
Article in The American journal of emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundIncidental findings in the Emergency Department (ED) are often not acted upon due to acuity of care and lack of referral pathways. Artificial intelligence (AI) can be used to combine heterogeneous data collected during ED encounters to computationally identify patients with specific disease phenotypes allowing for directed care-paths. We identified ED patients with undiagnosed Metabolic Dysfunction-Associated Liver Disease (MASLD) to demonstrate the feasibility of automated algorithms for clinical phenotypes.
methodsWe identified adults in 5 EDs with abdominal imaging between 1/1/2018-12/31/2023. Using a large language model, we included patients with hepatic steatosis on imaging and liver enzyme measurements. We excluded patients with prior liver disease. The K-means algorithm, an unsupervised machine learning method, was used to cluster patients into clinical phenotypes.
resultsWe identified 80,211 individuals with abdominal imaging, and 9103 (11.34%) met inclusion criteria. Clustering revealed three distinct phenotypes: Cluster 1 (Low Metabolic Burden Hepatic Steatosis), Cluster 2 (MASLD Dominant Hepatic Steatosis), and Cluster 3 (Non-MASLD Dominant Liver Disease). Cluster 2 (n = 1762, 19.4%) showed increased incidence of hypertension (76.6%), type 2 diabetes mellitus (53.7%), and dyslipidemia (48.6%). Cluster 3 (n = 520, 5.7%) had significantly elevated FIB-4 values (4.50 vs. 0.98 p < 0.001) but low incidence of MASLD risk factors. Finally, Cluster 1, the largest group (n = 6821, 74.9%) showed low FIB-4 values and low incidence of MASLD risk factors.
conclusionAn automatic AI-based algorithm identified a subset of patients with high risk factors for MASLD with low liver disease screening scores (FIB-4) allowing for future integration into health surveillance algorithms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.